Amazon Japan fined $244,000 for failing to remove Chinese counterfeit products
April 25 (UPI) -- Amazon Friday was ordered by Tokyo District Court to pay $244,167.02 to a Japanese medical device distributor for failing to remove Chinese counterfeit products from the platform.
Pulse oximeters distributor Excel Plan reported the counterfeit products listed on Amazon in Japan, but according to Judge Yuko Shintani Amazon failed to investigate and instead removed the entire product page.
That action, Excel Plan argued, hurt their ability to sell the genuine devices that measure blood oxygen levels.
Shintani ruled Amazon Japan's response was "indicative of willful misconduct, or at the very least, gross negligence."
The company argued that a "shared listings" Amazon feature put Chinese counterfeit pulse oximeters selling for roughly one-tenth the price side-by-side with real products. That, they argued in court, harmed both sellers and manufacturers of the real products.
"The ruling was a landmark in terms of acknowledging the obligation to build an appropriate (authentication) system, as businesses practically have no other option but to use platforms such as that of Amazon," An attorney representing Excel Plan and oximeter maker Try and E said.
Try and E made the oximeters but that company was not awarded any money in the court ruling.
When Amazon removed the page listing the genuine oximeter, Excel Plan said the company could not sell the genuine oximeters while Chinese counterfeits were still available.
Excel Plan asserted that Amazon's system of promoting the lowest priced products led to fake products being more visible, harming the company's ability to sell genuine products.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
UK's GCA to probe Amazon for alleged delays in supplier payments
UK's GCA launches probe into Amazon alleged delays in supplier payments The UK's Groceries Code Adjudicator (GCA) has initiated a probe into Amazon after concerns about alleged potential violations of regulations governing the timely payment to suppliers. The inquiry stems from suspicions that Amazon may have violated paragraph 5 of the code (no delay in payments) between 1 March 2022 and 20 June 2025. It will particularly scrutinise practices since 1 January 2024 to gain a comprehensive understanding of Amazon's current procedures. The investigation will assess the extent of any breaches, their impact on suppliers and the underlying causes. The GCA will examine Amazon's practices related to receiving goods, payment processes, handling supplier concerns about payment deductions and the use of settlements od deductions in its commercial negotiations. The GCA's decision to investigate follows previous interactions with Amazon. Mark White, the adjudicator, informed Amazon in 2024 that it must take decisive action to adhere to the code. White stated: 'Delays in payment can significantly harm suppliers. The alleged delays could expose Amazon suppliers to excessive risk and unexpected costs, potentially affecting their ability to invest and innovate. 'I decided to launch this targeted investigation based on the range of evidence I have seen from multiple sources. It will allow me to determine whether Amazon has breached paragraph 5 of the Groceries Code and the root cause of any breach.' The GCA states that despite Amazon's subsequent efforts, further detailed evidence from suppliers requires targeted investigation into payment practices. Reports have been received of other Groceries Code issues at Amazon. The GCA continues to work with Amazon to resolve these matters and remains prepared to initiate further investigations if required. White has called upon direct suppliers and stakeholders to contribute evidence and share their experiences of supplying to Amazon, as part of the GCA's evidence-gathering process for the ongoing investigation, stating: 'All responses will be completely confidential.' In June 2025, Amazon announced plans to downsize its corporate staff as it integrates generative AI technology into its business processes. "UK's GCA to probe Amazon for alleged delays in supplier payments" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Olympic sprint finalist Knighton at sports court for appeals in doping contamination case
LAUSANNE, Switzerland (AP) — United States sprinter Erriyon Knighton went to court Monday to defend his claim he was contaminated in a positive doping test case that risks a ban from the next world championships. A two-time Olympic finalist in the 200 meters aged just 21, Knighton was cleared to run at the Paris Summer Games last year only after an American tribunal ruled he was not at fault for the positive test for trenbolone, a steroid used in livestock farming. The World Anti-Doping Agency and track and field's Athletics Integrity Unit have challenged that ruling in combined appeals to the Court of Arbitration for Sport. CAS has scheduled the appeal hearing for two days and said a verdict is likely within several weeks. The U.S. track and field national championships start July 31 in Eugene, Oregon. They are trials to pick the U.S. team for the 2025 worlds that open Sept. 13 in Tokyo. Knighton's attorney Howard Jacobs suggested last year Knighton could be 'collateral damage' in an ongoing feud between WADA and the U.S. Anti-Doping Agency, fueled by how a case of alleged contamination of Chinese Olympic swimmers was handled by the global watchdog. USADA prosecuted Knighton's original case after he tested positive in March last year and accepted the 'no-fault' ruling based on the explanation the contamination was by oxtail from a bakery in central Florida. The USADA investigation included obtaining the meat and testing it, plus interviews with the manager of the bakery, Knighton, his girlfriend and his mother. They backed up the athlete's claim of contamination. In the Chinese case, an explanation of contamination with a banned heart medication in a hotel kitchen in 2021 was accepted without evidence backing the theory. WADA lawyers and officials decided the agency was unlikely to win any appeals brought to CAS without being able to gather independent evidence in China during the COVID-19 pandemic. Knighton is the sixth-fastest 200 runner in track history with a personal best time of 19.49 seconds set in 2022. Usain Bolt's world record is 19.19. He placed fourth in the 200 at past two Olympic Games, and took one silver medal and one bronze from the past two editions of worlds.
Yahoo
an hour ago
- Yahoo
‘Uncertain' 2025, M&A Deadlock Freeze $1 Trillion in PE Assets
The word of the year on Wall Street, without a doubt, has been uncertainty. It's the catch-all to describe everything from the fog of trade to nonstop geopolitical tensions. The inherent uncertainty of uncertainty also makes it hard to put a price tag on its impact, but last week, accounting firm PwC offered up a number: $1 trillion. That's the value of unsold assets that would have been returned to investors if it weren't for private equity groups holding on to them while remaining in an uncertainty-driven holding pattern. READ ALSO: Amazon's Driverless Cab Company Zoox Revs Up 'Toaster Taxis' and Cybersecurity Giant Palo Alto Networks Caught Between Opportunity and Maturity With New Year's fireworks in January, Wall Street was full of hope for an M&A boom driven by an incoming Trump administration with deregulation at the heart of its agenda — and lighter scrutiny from regulators when rules come into play. You know the deal: President Trump has focused on other priorities to start his second term, and the resulting market limbo has put deals on hold. According to PwC analysts, plans for initial public offerings (IPOs) of companies worth a combined $120 billion were shelved in the first three weeks of April. The Federal Reserve's decision to hold off on rate cuts to wait for the potential impacts of tariffs has had a resulting domino effect: a lack of cheap debt, as higher interest rates make debt more expensive. PwC noted that 30% of the $3 trillion that private equity firms have invested in roughly 30,000 companies has been held for more than five years, an unusually long period compared with the typical timetable for PE shops to turn a profit on an investment. This, they surmised, is in part because they have been less able to finance growing companies without cheap debt. 'In a typical M&A cycle, $1 trillion would have already been put back into the market,' Josh Smigel, a PwC partner, said on a media call. The data, meanwhile, looks like a set of spinning wheels: Deal volume and value have been more or less flat year-over-year, PwC said, with roughly 4,500 deals worth a total of $567 billion through May. In response to PwC's May Pulse Survey, 30% of respondents said they have paused or revisited deals because of tariff concerns, which would delay investor returns. 'While nearly half (48%) of the business executives surveyed expect today's uncertainty to last less than a year, many anticipate it could extend through the next presidential election,' reads the report. Change Your Mind? With the possibility that the worst of the tariff warring is over, May data provides a more optimistic scenario. The number of deals worth more than $100 million climbed 6.1% from April, according to an EY-Parthenon analysis of Dealogic data, though overall deal volume fell 6.2% from May 2024. This post first appeared on The Daily Upside. To receive delivering razor sharp analysis and perspective on all things finance, economics, and markets, subscribe to our free The Daily Upside newsletter. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
